Could stem cells reverse frailty? new study begins
Symptom relief
Not yet recruiting
This early-stage study tests a new stem cell product called Stemis™ in 12 adults aged 60-85 with mild to moderate frailty. Participants will receive either Stemis™ or a placebo via IV to see if it is safe and tolerable. The goal is to gather safety information, not to provide dir…
Phase: PHASE1 • Sponsor: Ji Yan Biomedical Co., Ltd. • Aim: Symptom relief
Last updated May 04, 2026 16:22 UTC